These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 29792934

  • 21. Tear biomarkers in latanoprost and bimatoprost treated eyes.
    Reddy S, Sahay P, Padhy D, Sarangi S, Suar M, Modak R, Rao A.
    PLoS One; 2018; 13(8):e0201740. PubMed ID: 30080906
    [Abstract] [Full Text] [Related]

  • 22. The Interaction of Nepafenac and Prostaglandin Analogs in Primary Open-angle Glaucoma Patients.
    Özyol P, Özyol E, Erdoğan BD.
    J Glaucoma; 2016 Mar; 25(3):e145-9. PubMed ID: 25493620
    [Abstract] [Full Text] [Related]

  • 23. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study.
    Maeda-Chubachi T, Chi-Burris K, Simons BD, Freedman SF, Khaw PT, Wirostko B, Yan E, A6111137 Study Group.
    Ophthalmology; 2011 Oct; 118(10):2014-21. PubMed ID: 21680022
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?
    Jamison A, Okafor L, Ullrich K, Schiedler V, Malhotra R.
    Aesthet Surg J; 2022 Oct 13; 42(11):1241-1249. PubMed ID: 35700523
    [Abstract] [Full Text] [Related]

  • 28. Changes in Prostaglandin-associated Periorbital Syndrome After Switch from Conventional Prostaglandin F2α Treatment to Omidenepag Isopropyl in 11 Consecutive Patients.
    Nakakura S, Terao E, Fujisawa Y, Tabuchi H, Kiuchi Y.
    J Glaucoma; 2020 Apr 13; 29(4):326-328. PubMed ID: 31913226
    [Abstract] [Full Text] [Related]

  • 29. Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?
    Kara C, Şen EM, Elgin KU, Serdar K, Yilmazbaş P.
    Int Ophthalmol; 2017 Jun 13; 37(3):619-626. PubMed ID: 27506567
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In Vivo Analysis of Prostaglandins-induced Ocular Surface and Periocular Adnexa Modifications in Patients with Glaucoma.
    DI Staso S, Agnifili L, Cecannecchia S, DI Gregorio A, Ciancaglini M.
    In Vivo; 2018 Jun 13; 32(2):211-220. PubMed ID: 29475902
    [Abstract] [Full Text] [Related]

  • 32. The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction.
    Mocan MC, Uzunosmanoglu E, Kocabeyoglu S, Karakaya J, Irkec M.
    J Glaucoma; 2016 Sep 13; 25(9):770-4. PubMed ID: 27513901
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficiency of glaucoma drug regulation in 5 European countries: a 1995-2006 longitudinal prescription analysis.
    De Natale R, Le Pen C, Berdeaux G.
    J Glaucoma; 2011 Sep 13; 20(4):234-9. PubMed ID: 21682002
    [Abstract] [Full Text] [Related]

  • 35. Physicians' treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma.
    Hahn SR, Kotak S, Tan J, Kim E.
    Curr Med Res Opin; 2010 Apr 13; 26(4):957-63. PubMed ID: 20163296
    [Abstract] [Full Text] [Related]

  • 36. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.
    Yoshino T, Fukuchi T, Togano T, Seki M, Ikegaki H, Abe H.
    Jpn J Ophthalmol; 2013 Mar 13; 57(2):172-8. PubMed ID: 23208023
    [Abstract] [Full Text] [Related]

  • 37. Periocular changes in topical bimatoprost and latanoprost use.
    Karslioğlu MZ, Hoşal MB, Tekeli O.
    Turk J Med Sci; 2015 Mar 13; 45(4):925-30. PubMed ID: 26422869
    [Abstract] [Full Text] [Related]

  • 38. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT, Lima L, Russ HH, Montiani-Ferreira F.
    J Ocul Pharmacol Ther; 2013 Nov 13; 29(9):817-20. PubMed ID: 23981234
    [Abstract] [Full Text] [Related]

  • 39. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES, Santana A, Rocha FN, Guapo GL, Costa VP.
    Arch Ophthalmol; 2005 Feb 13; 123(2):186-92. PubMed ID: 15710814
    [Abstract] [Full Text] [Related]

  • 40. Possible mechanism for the gastro-intestinal adverse effects upon topical application of Prostaglandin F₂α analogs.
    Cai S, Zhou X, Yan N, Liu X, Li X.
    Med Hypotheses; 2013 Jan 13; 80(1):32-5. PubMed ID: 23098372
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.